Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosis.

• Tác giả: Marc Ciosi, Carlos Estevez-Fraga, Mena Farag, Kate Fayer, Johan Gobom, Yara R Hassan, Amanda Heslegrave, Nicola Z Hobbs, Harpreet Hyare, Harry Knights, Douglas R Langbehn, Christelle Langley, Michela Leocadi, Jeffrey D Long, Ian B Malone, Darren G Monckton, Michael J Murphy, Mitsuko Nakajima, Christopher S Parker, Nehaa K P Ponraj, Geraint Rees, Trevor W Robbins, John Rönnholm, James B Rowe, Barbara J Sahakian, Cristina Sampaio, Rachael I Scahill, Sarah J Tabrizi, Olivia Thackeray, Sophia Weiner, Edward J Wild, Henrik Zetterberg, Hui Zhang
• Ngôn ngữ: eng
• Thông tin xuất bản: United States : Nature medicine , 2025
• Bộ sưu tập: NCBI
• ID: 720905

Tóm tắt

 Huntington's disease (HD) is an autosomal dominant neurodegenerative disease with the age at which characteristic symptoms manifest strongly influenced by inherited HTT CAG length. Somatic CAG expansion occurs throughout life and understanding the impact of somatic expansion on neurodegeneration is key to developing therapeutic targets. In 57 HD gene expanded (HDGE) individuals, ~23 years before their predicted clinical motor diagnosis, no significant decline in clinical, cognitive or neuropsychiatric function was observed over 4.5 years compared with 46 controls (false discovery rate (FDR) >
  0.3). However, cerebrospinal fluid (CSF) markers showed very early signs of neurodegeneration in HDGE with elevated neurofilament light (NfL) protein, an indicator of neuroaxonal damage (FDR = 3.2 × 10